Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group. - Mascarenhas L; Lyden ER; Breitfeld PP; Walterhouse DO; Donaldson SS; Rodeberg DA; Parham DM; Anderson JR; Meyer WH; Hawkins DS (Cancer, 2019)